Optimizing the Benefits of Roux-en-Y Gastric Bypass with Preoperative Optimization of Diabetes Mellitus: Is There an Ideal Glycosylated Hemoglobin Level?

Roux-en-Y gastric bypass (RYGB) affords a long-term, durable approach to the management of diabetes mellitus (DM) in morbidly obese patients. Nevertheless, patients with DM are at an increased risk for 30-day wound events and additional morbidity and mortality compared with patients without DM. The purpose of our study was to determine if there is a preoperative glycosylated hemoglobin (HgA1c) target level that can be used as a surrogate for optimization of DM in diabetic patients before RYGB.

Source: Journal of the American College of Surgeons - September 30, 2020 Category: Surgery Authors: Ivy N. Haskins, Hope T. Jackson, Jeffrey Lipman, Andrew Dunn Sparks, Khashayar Vaziri, Timothy M. Farrell Tags: Bariatric and foregut Source Type: research